Light

The first human study of Neuralink, a brain-chip firm founded by billionaire entrepreneur Elon Musk, has begun. The clinical trial will focus on patients with paralysis caused by cervical spinal cord injury or amyotrophic lateral sclerosis (ALS). The announcement was made on September 19, however the exact number of participants is still unknown. Initially, Neuralink … [Read more…]